70 innovative cancer treatments have been launched in the past five years. This significant increase in innovative therapies available to patients resulted in the global oncology market value reaching $107 billion in 2015.
By 2020 the total oncology drug market is expected to reach USD150 billion growing on average by 9 percent per year. A significant portion of the increase is expected to come as a result of the entry of innovative treatments, in particular, immunoonclogy therapies. Healthcare systems are also expected to favor “results based payment” further driving opportunities for novel, safer and more efficacious therapeutics.
We are looking for new therapies targeting all major cancer types including Blood cancer, Breast cancer, gastrointestinal tract cancer, Prostate cancer, Lung Cancer, Skin Cancer and other cancer.